findmyKOL
Clinical trialNCT05480046CompletedObservational

Non-interventional Study of Risperidone ISM® in Schizophrenia Patients Hospitalised Due to a Relapse

SponsorRovi Pharmaceuticals LaboratoriesEnrollment275Schizophrenia
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is a prospective, non-interventional, multicentre study designed to collect information about the effectiveness, safety and tolerability of Risperidone ISM in patients diagnosed with schizophrenia who are suffering an acute exacerbation, according to routine clinical practice.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

77 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Germany
  • Investigational Site Number de-06

    Aachen, Germany

  • Investigational Site Number de-14

    Ansbach, Germany

  • Investigational Site Number de-23

    Bayreuth, Germany

  • Investigational Site Number de-10

    Berlin, Germany

  • Investigational Site Number de-12

    Berlin, Germany

  • Investigational Site Number de-15

    Berlin, Germany

  • Investigational Site Number de-07

    Bonn, Germany

  • Investigational Site Number de-16

    Bonn, Germany

  • Investigational Site Number de-02

    Chemnitz, Germany

  • Investigational Site Number de-03

    Dortmund, Germany

  • Investigational Site Number de-25

    Eberswalde, Germany

  • Investigational Site Number de-01

    Essen, Germany

  • Investigational Site Number de-08

    Greifswald, Germany

  • Investigational Site Number de-22

    Hamburg, Germany

  • Investigational Site Number de-20

    Hemer, Germany

  • Investigational Site Number de-19

    Leipzig, Germany

  • Investigational Site Number de-05

    Mannheim, Germany

  • Investigational Site Number de-04

    Munich, Germany

  • Investigational Site Number de-09

    München, Germany

  • Investigational Site Number de-24

    Neustadt, Germany

  • Investigational Site Number de-13

    Werneck, Germany

Italy
  • Investigational Site Number It-32

    Ancona, Italy

  • Investigational Site Number It-19

    Bolzano, Italy

  • Investigational Site Number It-24

    Brescia, Italy

  • Investigational Site Number It-65

    Brindisi, Italy

  • Investigational Site Number It-20

    Crema, Italy

  • Investigational Site Number It-41

    Foggia, Italy

  • Investigational Site Number It-03

    Legnano, Italy

  • Investigational Site Number It-47

    Manfredonia, Italy

  • Investigational Site Number It-06

    Milan, Italy

  • Investigational Site Number It-42

    Milan, Italy

  • Investigational Site Number It-18

    Montichiari, Italy

  • Investigational Site Number It-113

    Palermo, Italy

  • Investigational Site Number It-44

    Putignano, Italy

  • Investigational Site Number It-97

    Sant'Agata di Militello, Italy

  • Investigational Site Number It-90

    Vimercate, Italy

Portugal
  • Investigational Site Number Pt-25

    Beja, Portugal

  • Investigational Site Number Pt-24

    Braga, Portugal

  • Investigational Site Number Pt-01

    Coimbra, Portugal

  • Investigational Site Number Pt-33

    Funchal, Portugal

37 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Risperidone ISM
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
18 Oct 2022
Primary completion
13 Mar 2025
Completion
13 Mar 2025
Last update posted
5 Dec 2025
Registered enrollment
275
Registry id
NCT05480046
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.